<VariationArchive VariationID="813903" VariationName="NM_025137.4(SPG11):c.315del (p.Ala106fs)" VariationType="Deletion" Accession="VCV000813903" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-30" DateCreated="2020-03-01" MostRecentSubmission="2020-03-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="802202" VariationID="813903">
      <GeneList>
        <Gene Symbol="SPG11" FullName="SPG11 vesicle trafficking associated, spatacsin" GeneID="80208" HGNC_ID="HGNC:11226" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="44562696" stop="44663662" display_start="44562696" display_stop="44663662" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="44854893" stop="44955875" display_start="44854893" display_stop="44955875" Strand="-" />
          </Location>
          <OMIM>610844</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025137.4(SPG11):c.315del (p.Ala106fs)</Name>
      <CanonicalSPDI>NC_000015.10:44660558:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="44660559" stop="44660559" display_start="44660559" display_stop="44660559" variantLength="1" positionVCF="44660558" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="44952757" stop="44952757" display_start="44952757" display_stop="44952757" variantLength="1" referenceAllele="G" alternateAllele="-" positionVCF="44952756" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>A106fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.44660559del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.44660559del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.44952757del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.44952757del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008885.1" sequenceAccession="NG_008885" sequenceVersion="1" change="g.8120del">
            <Expression>NG_008885.1:g.8120del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160227.2" sequenceAccession="NM_001160227" sequenceVersion="2" change="c.315del">
            <Expression>NM_001160227.2:c.315del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153699.1" sequenceAccession="NP_001153699" sequenceVersion="1" change="p.Ala106fs">
            <Expression>NP_001153699.1:p.Ala106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025137.4" sequenceAccession="NM_025137" sequenceVersion="4" change="c.315del" MANESelect="true">
            <Expression>NM_025137.4:c.315del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079413.3" sequenceAccession="NP_079413" sequenceVersion="3" change="p.Ala106fs">
            <Expression>NP_079413.3:p.Ala106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1595940106" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025137.4(SPG11):c.315del (p.Ala106fs) AND Hereditary spastic paraplegia 11" Accession="RCV001004871" Version="2">
        <ClassifiedConditionList TraitSetID="295">
          <ClassifiedCondition DB="MedGen" ID="C1858479">Hereditary spastic paraplegia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-12-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-12-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-01" MostRecentSubmission="2020-03-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11, autosomal recessive</ElementValue>
                <XRef ID="Spastic+paraplegia+11/6677" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia,  mental retardation and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary spastic paraplegia mental impairment and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 11</ElementValue>
                <XRef ID="MONDO:0011445" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nakamura Osame syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive hereditary spastic paraplegia, mental impairment, and thin corpus callosum</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP-TCC</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPG11</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset.</Attribute>
                <XRef ID="NBK1210" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4919" />
                <XRef ID="4919" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301389</ID>
                <ID Source="BookShelf">NBK1210</ID>
              </Citation>
              <XRef ID="2822" DB="Orphanet" />
              <XRef ID="C1858479" DB="MedGen" />
              <XRef ID="MONDO:0011445" DB="MONDO" />
              <XRef Type="MIM" ID="604360" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2297566" SubmissionDate="2019-10-03" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="4647_2|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164352" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Ala106LeufsTer15 variant in SPG11 was identified by our study in the compound heterozygous state, along with a pathogenic variant, in two siblings with spastic paraplegia. The presence of this variant in combination with a pathogenic variant and in an individual with spastic paraplegia increases the likelihood that the p.Ala106LeufsTer15 variant is pathogenic. The p.Ala106LeufsTer15 variant in SPG11 has not been previously reported in individuals with spastic paraplegia and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 106 and leads to a premature termination codon 15 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SPG11 gene is an established disease mechanism in autosomal recessive spastic paraplegia. In summary, this variant meets criteria to be classified as pathogenic for SPG11 in an autosomal recessive manner based on the predicted impact of the variant and the presence of the variant in combination with another pathogenic variant in an individual with spastic paraplegia. ACMG/AMP Criteria applied: PM2, PVS1, PM3 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>WES</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="-" referenceAllele="G" start="44952757" stop="44952757" variantLength="1" />
          </Location>
          <OtherNameList>
            <Name>p.Ala106LeufsTer15</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6387569</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2297566" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

